Ceo | Healthcare | Private Equity | International | Acquisitions | Digital | Lean
Current❖ IMV Technologies - a company of Montagu Private Equity portfolio✧ World leader in animal and human assisted reproduction biotechnologies. Operates in the areas of artificial insemination and veterinary imaging instruments and consumables✧ Global company with $120+M Sales in 120 countries. 600 associates. Private Equity owned❖ STAKESBalanced Growth, Profitability and Shareholder stakes➊ Grow Sales: organic & acquisitions➋ Increase profitability (EBITDA) and free cash flow➌ Lead shareholder and bank changes and run new governance❖ MISSIONS / RESULTS➊ Lead business Growth✧ Design and execute a growth strategy: sales growth and EBITDA improvement✧ Grow animal and human reproduction business. Through new product launches and commercial efficiency✧ Enter into a new double digit growth market✧ Digitalize Marketing and Sales✧ Accelerate Innovation and R&D with additional investments, alliances & Lean processes✧ Close M&A deals➋ Increase EBITDA and Free Cash Flow✧ Drive business volume growth✧ Implement pricing management✧ Drive continuous Lean Manufacturing conversion✧ Conduct Inventory reductions for working capital and free cash flow improvement➌ Reinforce Teams - Build talent pool - Improve engagement.➍ Achieve solid foundations✧ Accelerate sustainability through CSR program✧ Manage risks & compliance✧ Transform the business processes with the Lean IMV Technologies Business System (IBS)❺ Lead shareholder and bank changes and run new governance✧ Drive shareholder change with Private Equity firm Qualium Investissement and investment bank: Montagu Private Equity new shareholder✧ Set up and run governance with new shareholder✧ Appoint new banks to finance the new round of LBOCEO – International – Asia Europe USA – Private Equity – LBO – Healthcare – Medical Devices – Commercial – Transformation – Digital – Lean – Quality Assurance – Regulatory Affairs